539 results on '"Murray, David L."'
Search Results
102. Glycosylation of Immunoglobulin Light Chains Is Highly Prevalent in Cold Agglutinin Disease
103. Evolution of Myeloma Testing in Clinical Chemistry with Mass Spectrometry
104. Correlation Between Kappa Prozone Effect and IgA Kappa M Proteins in Serum Free Light-Chain Assay
105. Direct Detection of Monoclonal Free Light Chains in Serum by Use of Immunoenrichment-Coupled MALDI-TOF Mass Spectrometry
106. Commentary
107. Clinical features, laboratory characteristics and outcomes of patients with renal versus cardiac light chain amyloidosis
108. Classification of Plasma Cell Disorders by 21 Tesla Fourier Transform Ion Cyclotron Resonance Top-Down and Middle-Down MS/MS Analysis of Monoclonal Immunoglobulin Light Chains in Human Serum
109. Cloning and characterization of a novel regulator of G protein signalling in human platelets
110. Implications of detecting serum monoclonal protein by MASS‐fix following stem cell transplantation in multiple myeloma.
111. Liquid Chromatography-Tandem Mass Spectrometry-Based α1-Antitrypsin (AAT) Testing.
112. Systemic AL amyloidosis with an undetectable plasma cell dyscrasia: A zebra without stripes.
113. Mass Spectrometry to Measure Response in Immunoglobulin Light Chain Amyloidosis (AL)
114. MASS-FIX may allow identification of patients at risk for light chain amyloidosis before the onset of symptoms
115. Risk of MGUS in relatives of multiple myeloma cases by clinical and tumor characteristics
116. Accumulation of Gadolinium in Human Cerebrospinal Fluid after Gadobutrol-enhanced MR Imaging: A Prospective Observational Cohort Study
117. CSF free light chain identification of demyelinating disease: comparison with oligoclonal banding and other CSF indexes
118. Restricted IgG-Kappa and Free Alpha-Heavy-Chain Bands in an Asymptomatic 62-Year-Old Man
119. Pharmacokinetics of rituximab and clinical outcomes in patients with anti-neutrophil cytoplasmic antibody associated vasculitis
120. Screening and Diagnosis of Monoclonal Gammopathies: An International Survey of Laboratory Practice
121. Gadolinium Deposition in Human Brain Tissues after Contrast-enhanced MR Imaging in Adult Patients without Intracranial Abnormalities
122. Comparison of Gadolinium Concentrations within Multiple Rat Organs after Intravenous Administration of Linear versus Macrocyclic Gadolinium Chelates
123. A multi-center method comparison for detection of autoantibodies to human complement Factor H (AFH)
124. Intracranial Gadolinium Deposition Following Gadodiamide-Enhanced Magnetic Resonance Imaging in Pediatric Patients
125. The utility of MASS-FIX to detect and monitor monoclonal proteins in the clinic
126. Characterizing the amyloidogenic protein in patients with light chain amyloidosis using mass spectrometry.
127. Assessment of renal response with urinary exosomes in patients with AL amyloidosis: A proof of concept
128. Identification of Friend or Foe: The Laboratory Challenge of Differentiating M-Proteins from Monoclonal Antibody Therapies
129. Chloroplasts ofArabidopsis thaliana homozygous for the ch-1 locus lack chlorophyllb, lack stable LHCPII and have stacked thylakoids
130. Multimedia & Educational Resources Contributors
131. Comprehensive Assessment of M-Proteins Using Nanobody Enrichment Coupled to MALDI-TOF Mass Spectrometry
132. Screening Method for M-Proteins in Serum Using Nanobody Enrichment Coupled to MALDI-TOF Mass Spectrometry
133. Using Mass Spectrometry to Quantify Rituximab and Perform Individualized Immunoglobulin Phenotyping in ANCA-Associated Vasculitis
134. Clonotypic Light Chain Peptides Identified for Monitoring Minimal Residual Disease in Multiple Myeloma without Bone Marrow Aspiration
135. Restricted IgG-Kappa and Free Alpha-Heavy-Chain Bands in an Asymptomatic 62-Year-Old Man.
136. A Rapid MALDI-TOF Method for Isotyping and Quantitating M-Proteins in a Single Assay: Longitudinal Comparison to Serum Protein Electrophoresis and Hevylite for Monitoring Patients with Monoclonal Gammopathies
137. Novel Genetic Variants in Complement-Mediated Thrombotic Microangiopath
138. Subset of Kappa and Lambda Germline Sequences Result in Light Chains with a Higher Molecular Mass Phenotype
139. Using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry to detect monoclonal immunoglobulin light chains in serum and urine
140. Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging
141. Monitoring IgA Multiple Myeloma: Immunoglobulin Heavy/Light Chain Assays
142. Evaluating Pembrolizumab Interference with Monoclonal Protein Detection By Immunofixation and By MALDI-TOF Mass Spectrometry (MASS-FIX)
143. Atypical Hemolytic Uremic Syndrome-Clinical Presentation, Treatment, and Short Term Outcomes: The Mayo Clinic Experience
144. Friction stir processing of nickel aluminum propeller bronze in comparison to fusion welds
145. Letter to the Editor.
146. High Sensitivity Detection of Malignant-Specific M-Proteins Using Mass Spectrometry
147. Phenotyping Polyclonal Kappa and Lambda Light Chain Molecular Mass Distributions in Patient Serum Using Mass Spectrometry
148. Quantification of Serum IgG Subclasses by Use of Subclass-Specific Tryptic Peptides and Liquid Chromatography–Tandem Mass Spectrometry
149. Sa1268 Clinical Development of an Electrochemiluminescent Immunoassay to Measure Antibodies-to-Infliximab
150. Sa1252 Serum Infliximab Quantitation by LC-MS/MS in Patients Treated for Inflammatory Disorders
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.